Victory Capital Management
PAHC icon

Victory Capital Management’s Phibro Animal Health PAHC Stock Holding History

Victory Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-86,988
Closed -$1.17M – 2666
2022
Q4 		$1.17M Sell
86,988
-231,633
-73% -$3.11M ﹤0.01% 1651
2022
Q3 		$4.23M Sell
318,621
-129,019
-29% -$2.23M ﹤0.01% 1282
2022
Q2 		$8.56M Buy
447,640
+9,800
+2% +$186K 0.01% 1114
2022
Q1 		$7.88M Buy
437,840
+145,990
+50% +$2.95M 0.01% 1184
2021
Q4 		$5.96M Buy
291,850
+38,171
+15% +$815K 0.01% 1285
2021
Q3 		$5.46M Buy
253,679
+24,040
+10% +$579K 0.01% 1308
2021
Q2 		$6.63M Buy
229,639
+47,940
+26% +$1.3M 0.01% 1251
2021
Q1 		$4.43M Buy
181,699
+171,251
+1,639% +$3.87M ﹤0.01% 1383
2020
Q4 		$203K Sell
10,448
-18,582
-64% -$342K ﹤0.01% 2371
2020
Q3 		$505K Sell
29,030
-702
-2% -$15K ﹤0.01% 1951
2020
Q2 		$781K Sell
29,732
-85,864
-74% -$2.13M ﹤0.01% 1831
2020
Q1 		$2.79M Buy
115,596
+61,705
+114% +$1.51M ﹤0.01% 1460
2019
Q4 		$1.34M Buy
53,891
+6,746
+14% +$157K ﹤0.01% 1654
2019
Q3 		$1.01M Buy
47,145
+42,704
+962% +$1.17M ﹤0.01% 1700
2019
Q2 		$141K Sell
4,441
-7,713
-63% -$242K ﹤0.01% 1504
2019
Q1 		$401K Buy
12,154
+1,398
+13% +$43.5K ﹤0.01% 1363
2018
Q4 		$346K Buy
10,756
+419
+4% +$15.8K ﹤0.01% 1445
2018
Q3 		$443K Buy
10,337
+2,242
+28% +$106K ﹤0.01% 1455
2018
Q2 		$373K Buy
8,095
+1,108
+16% +$49.1K ﹤0.01% 1453
2018
Q1 		$277K Buy
6,987
+1,304
+23% +$48.3K ﹤0.01% 1494
2017
Q4 		$190K Buy
5,683
+493
+9% +$17.5K ﹤0.01% 1584
2017
Q3 		$192K Sell
5,190
-190
-4% -$7.13K ﹤0.01% 1546
2017
Q2 		$199K Buy
5,380
+807
+18% +$26.3K ﹤0.01% 1452
2017
Q1 		$129K Buy
4,573
+2,021
+79% +$57K ﹤0.01% 1560
2016
Q4 		$75K Sell
2,552
-62
-2% -$1.69K ﹤0.01% 1644
2016
Q3 		$71K Buy
2,614
+289
+12% +$6.54K ﹤0.01% 1644
2016
Q2 		$43K Buy
2,325
+1,013
+77% +$21.1K ﹤0.01% 1543
2016
Q1 		$35K Buy
+1,312
New +$37.6K ﹤0.01% 1526

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management's PAHC Position: Q1 2023 in Review

Victory Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2023, closing a stake of 86,988 shares — an estimated $1.17M sold.

Victory Capital Management first reported a position in PAHC in Q1 2016 and held it in 28 quarters. The position peaked at $8.56M in Q2 2022. 133 funds tracked by Wall St. Rank hold PAHC as of Q1 2023.

  • Victory Capital Management reported no remaining Phibro Animal Health position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 86,988 Phibro Animal Health shares in Q1 2023, an estimated $1.17M.
  • Victory Capital Management first reported a position in Phibro Animal Health in Q1 2016 and held it in 28 quarters.
  • Victory Capital Management's Phibro Animal Health position peaked at $8.56M in Q2 2022.
  • 133 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.